Posters sap weg msi high colon cancer immunotherapy België Boren Hysterisch Verslaving
Cells | Free Full-Text | Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study | HTML
PDF) The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
Checkpoint Inhibition: A Promising Immunotherapeutic Approach for Colorectal Cancer | Personalized Medicine in Oncology
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis | British Journal of Cancer
Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO
References in International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet
PDF) Immunotherapy with immune checkpoint inhibitors in colorectal cancer: What is the future beyond deficient mismatch-repair tumours?
PEMBROLIZUMAB AS A NEW, FIRST-LINE STANDARD OF CARE IN COLORECTAL CANCER - BJMO
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet
Pathological complete response after neoadjuvant immunotherapy for a patient with microsatellite instability locally advanced rectal cancer: should we adapt our standard management for these patients? - European Journal of Cancer
Frontiers | Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer? | Immunology
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies - Annals of Oncology
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
Immunotherapy in the treatment of colorectal cancer: a new kid on the block
Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ | EMBO Molecular Medicine
Immunotherapy Combination Approved for Colorectal Cancer - National Cancer Institute
Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer - The Journal of Molecular Diagnostics
VIB - Biocartis ontvangt subsidie voor ontwikkeling van volledig geautomatiseerde MSI test
Colorectal Cancer
Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO
Frontiers | Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies | Immunology
Revolutionary diagnostic cancer test - VIB
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
Immunotherapy in colorectal cancer treatment: actual landscape and future perspectives